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Background: Aerobic exercise training (physical activity for improving cardiorespiratory fitness) 
represents a promising approach for managing cognitive impairment in multiple sclerosis (MS). 
However, there is limited evidence that levels of physical activity and fitness are associated with 
cognition in progressive MS.  
 
Objective: We examined associations among cardiorespiratory fitness, moderate-to-vigorous physical 
activity (MVPA), and cognitive performance in a large, international progressive MS sample.  
 
Methods: 240 European and North American persons with progressive MS underwent cardiorespiratory 
fitness measurement on a recumbent stepper, wore an ActiGraph GT3X+ accelerometer for 7-days for 
measuring MVPA, and underwent the Brief International Cognitive Assessment in MS.   
 
Results: Cardiorespiratory fitness was not significantly correlated with Symbol Digit Modalities Test 
(SDMT; r=−.01;r=−.04), California Verbal Learning Test-II (CVLT-II; r=.05;r=.05), or Brief Visuospatial 
Memory Test-Revised (BVMT-R; r=−.14;r=−.14) z-scores controlling for age, sex, and education. MVPA 
and SDMT (r=.05), CVLT-II (r=−.07), and BVMT-R (r=.01) z-scores were not significantly correlated. 
 
Conclusion: Cardiorespiratory fitness and MVPA were not associated with cognition in this large 
progressive MS sample, yet these outcomes represent critical manipulation checks for documenting the 
success of the CogEx trial. This highlights the importance of examining other exercise-related 
mechanisms-of-action for improving cognition in progressive MS.   
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 Multiple sclerosis (MS) is a neurological disease that affects upwards of 2.5 million people 
worldwide.[1] Progressive forms of the disease are typified by neurodegeneration and axonal 
transection, resulting in profound brain damage.[2,3] Cognitive impairment, in particular, represents a 
hallmark consequence of progressive MS. Recent epidemiological data suggest that approximately 75% 
of progressive MS patients demonstrate impaired cognition based on objective neuropsychological tests 
of cognitive processing speed (CPS), learning and memory, and executive functioning.[4] Progressive 
MS-related cognitive impairment is associated with unemployment, social isolation, and reduced quality 
of life, and is unmitigated by pharmacotherapies.[3] This highlights the importance of considering other 
approaches for managing cognitive dysfunction in progressive MS.[3] 
 Aerobic exercise training, defined as chronic physical activity for improving or maintaining 
cardiorespiratory fitness,[5] represents a promising approach for managing cognitive impairment in 
progressive MS.[3,6,7] This is based, in part, on evidence reporting on AET-related cognitive 
improvements in persons with relapsing-remitting MS[6] and older adults who often have progressive 
brain atrophy and associated loss of function over time.[8] By comparison, we are aware of only one 
study reporting on aerobic exercise training-related cognitive benefits in progressive MS. That pilot 
randomized controlled trial (RCT) reported that 8-10 weeks of aerobic cycle ergometer exercise training 
was associated with improvements in cardiorespiratory fitness, verbal memory, and alertness in a small 
sample of persons with progressive MS.[9]  
One approach for informing the development of future aerobic exercise training interventions 
for improving cognition involves examining associations among cardiorespiratory fitness, physical 
activity (as cross-sectional surrogates for components of aerobic exercise), and cognition in this 
population. There is evidence describing significant associations between cardiorespiratory fitness and 
cognition,[10-12] and physical activity and cognition,[13] respectively, in non-progressive MS samples. 
Several recent studies have reported particularly strong correlations in cognitively-impaired MS 
samples;[11,13] that early-stage evidence has directly informed the development of ongoing RCTs.[6] 
Such results support the possibility of strong associations among cardiorespiratory fitness, physical 
activity, and cognition in progressive MS cohorts, and further might allow for head-to-head 
comparisons of cardiorespiratory fitness and physical activity as correlates of cognitive performance in 
this population. Indeed, the possibility of differential associations between cardiorespiratory fitness and 
physical activity with cognition would provide important information on the potential foci (i.e., 
improving fitness and/or enhancing physical activity behavior) of subsequent aerobic exercise training 
interventions in progressive MS. 
 The current study involved a cross-sectional analysis of associations among measures of 
cardiorespiratory fitness, free-living moderate-to-vigorous physical activity (MVPA), and cognitive 
performance in a large, international sample of persons with progressive MS who presented with 
objective CPS impairment from the multi-site CogEx RCT[14]. Based on previous evidence of particularly 
strong associations among cardiorespiratory fitness, free-living physical activity, and cognitive 
performance in cognitively-impaired persons with MS,[11,13] the overall hypothesis was that higher 
cardiorespiratory fitness and levels of free-living MVPA would similarly be associated with better 
cognitive performance. 
 
Materials and Methods 
The current study represents analyses of currently accrued baseline data from a multi-arm, 
randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise training on 
cognition and neuroimaging outcomes in persons with progressive MS and CPS impairment across 11 
sites in North America and Europe (i.e., CogEx). The complete study protocol is described elsewhere.[14] 
Of note, all procedures described below were standardized across sites via comprehensive in-person 
and remote training, along with quality control on a case-by-case basis. 
 
Participants  
Participants were recruited via inpatient and outpatient MS clinics, databases of previous 
research participants, and via media advertising in the community. Prospective participants underwent 
an initial telephone screen for demographic and clinical inclusion/exclusion criteria, followed by an in-
person screen. All participants (a) had a clinically-definite progressive MS diagnosis; (b) were between 
25-65 years of age; (c) were ambulatory with or without assistance; (d) were relapse-free without acute 
steroid use for 90 days; (e) had no history of neurological disorders besides MS; (f) did not have severe 
psychiatric illness; (g) did not use drugs that could affect cognition (excluding cannabis); (h) 
demonstrated low risk for contraindications for physical activity; and (i) were insufficiently active based 
on a Health Contribution Score of the Godin Leisure-Time Exercise Questionnaire <23 units.[15] To pass 
the in-person screen, participants (a) demonstrated corrected visual acuity better than 20/80; (b) were 
not severely depressed based on Beck Depression Inventory-II scores <29;[16] (c) demonstrated intact 
language comprehension based on Token Test scores <28;[17] and (d) demonstrated impaired CPS 
based on Symbol Digit Modalities Test (SDMT) scores ≥1.282 SD-units below the age-, sex-, and 
education- adjusted normative score (i.e., ≤10th percentile). As the CogEx study is an international, multi-
site trial, the normative SDMT scores that were used were specific for each country wherein data were 
collected (i.e., Belgium, Canada, Denmark, Italy, United Kingdom, United States).[18-22]  
 
Outcomes 
Cardiorespiratory Fitness. Cardiorespiratory fitness was measured as peak oxygen consumption 
(VO2peak; ml/kg/min) and peak work rate (WRpeak; W) using an incremental exercise test on a recumbent 
stepper (Nustep T5XR, Nustep Inc, Ann Arbor, MI) and an open-circuit spirometry system for analyzing 
expired gases. We included WRpeak, as this might represent an integrative fitness measure in persons 
with MS.[23] Participants were appropriately positioned in the stepper, fit with a mouthpiece and/or 
mask for collecting expired gases, and were read scripted, standardized procedures for the incremental 
exercise test and reporting of rating of perceived exertion (RPE). After an initial 1-minute rest period on 
the stepper, participants performed a 1-minute warm-up at 15 W, stepping at a cadence of 60 
steps/minute. The initial WR for the incremental exercise test was 15 W, and the WR continuously 
increased at a rate of 5-10 W/minute; participants stepped at prescribed cadence rates with 
metronomic assistance to correspond with increasing WR.[24] Participants stepped until reaching 
volitional fatigue or when cadence fell ≥15 steps/minute below the prescribed value for 30 seconds. 
During the IET, the open-circuit spirometry system continuously measured VO2, respiratory exchange 
ratio (RER), and heart rate (HR) using a HR monitor or electrocardiogram; those outcomes were 
expressed as 20-second averages. WR, RPE, and steps/minute were recorded each minute during the 
test. VO2peak was based on highest recorded 20-second VO2 value when two of four criteria were 
satisfied: (1) VO2 plateau with increasing WR; (2) RER ≥1.10; (3) peak HR within 10 beats per minute of 
age-predicted maximum (i.e., 220-age); or (4) peak RPE ≥17. WRpeak was based on the recorded WR at 
test termination. 
Free-Living MVPA. Free-living MVPA was measured using waist-worn ActiGraph model GT3x+ 
accelerometers (Actigraph, Inc., Pensacola, FL) over a seven-day period. Participants wore the 
accelerometer on an elastic belt around the waist over the non-dominant hip during the waking hours of 
a seven-day period, and further recorded wear-time in a log for compliance. The raw accelerometer data 
were downloaded and processed using the low frequency extension into 60-second epochs using 
ActiLife (Actigraph Corporation, FL) software. The data were then scored for wear-time and minutes/day 
of MVPA using MS-specific cut-points.[25] Days consisting of ≥10 hours of wear time (≥600 minutes) 
were considered valid and cases demonstrating ≥1 valid day were included in the analyses.[26] This was 
confirmed using the aforementioned compliance log. Free-living MVPA was expressed in minutes/day 
and percent of total wear-time (i.e., percent MVPA), and the primary accelerometer outcomes were 
average minutes/day of MVPA and percent MVPA across valid days.  
Cognitive Performance. Cognitive performance was measured using the Brief International 
Cognitive Assessment for MS (BICAMS) neuropsychological battery. The BICAMS includes the SDMT as a 
test of CPS, the California Verbal Learning Test-II (CVLT-II) as a test of verbal learning and memory, and 
the Brief Visuospatial Memory Test-Revised (BVMT-R) as a test of visuospatial learning and memory.[22] 
BICAMS scores have been validated in Danish,[20] Dutch,[18] Italian,[21] and English[22] (i.e., the 
languages spoken at the CogEx study sites). The SDMT, CVLT-II, and BVMT-R were administered and 
scored according to standardized procedures.[22] Raw SDMT, CVLT-II, and BVMT-R scores, respectively, 
were converted to country-specific z-scores that adjusted for age-, sex-, and education;[18-22] those z-
scores represented the primary cognitive outcomes.  
Ambulatory Disability Status. Ambulatory disability status was measured using the Expanded 
Disability Status Scale (EDSS).[27] Along with confirming a clinically-definite progressive MS diagnosis, 
the participant’s neurologist provided the most recent EDSS score at the time of the telephone screen. 
As this was not tightly standardized across sites, we further administered the six-minute walk (6MW) 
test[28] as a measure of walking endurance for better characterizing ambulatory disability status. The 
6MW was administered using standardized procedures for persons with MS,[28] and the primary 
outcome was total distance walked (m) in the six-minute period.  
 
Procedures 
 The study was approved by each site’s research ethics board or institutional review board, and 
all participants provided written informed consent. After satisfying the in-person screen, participants 
underwent the BICAMS neuropsychological battery, 6MW, and completed questionnaires assessing 
demographic and clinical characteristics; participants subsequently underwent the incremental exercise 
test. We note that there was at least 15-minutes of rest in between administration of the 6MW and 
incremental exercise test, and that the order of outcome assessments was standardized across sites. 
Following incremental exercise test administration, participants were provided with the accelerometer, 
elastic waist band, log book, along with instructions for wearing the device for seven days. Upon 




    Across the 11 CogEx study sites, data were entered using REDCap®. The data were analyzed by 
the study biostatistician (AS) using SAS v9.4 software (SAS Inc., Cary, NC), and are reported in text and 
tables as mean (SD) unless otherwise noted. The primary analyses involved bivariate Pearson product-
moment correlations (r) among measures of cardiorespiratory fitness (i.e., VO2peak, WRpeak), free-living 
MVPA (i.e., minutes/day of MVPA, percent MVPA), and cognitive performance (i.e., SDMT z-score, 
CVLT-II z-score, BVMT-R z-score), respectively. We performed additional bivariate Pearson correlations 
among the cardiorespiratory fitness, free-living MVPA, and 6MW data to examine possible 
specificity/generality, given well-established correlations among fitness, physical activity, and walking 
endurance in persons with MS across the disability spectrum.[29] For the bivariate correlations, we 
applied a Benjamini-Hochberg false discovery rate correction for multiple comparisons at a rate of 5%; 
this resulted in a final adjusted value of .015 for statistical significance. Values for correlation 




 240 North American and European persons with progressive MS satisfied inclusion/exclusion 
criteria and provided baseline (trial) data on the outcomes; the baseline data were analyzed as of 14 
June 2021. Demographic and clinical characteristics of the full sample are reported in Table 1. Overall, 
the sample was predominantly female (61%), married (60%), well-educated (45% College educated), but 
unemployed (66%). Approximately 73% of participants presented with a secondary progressive MS 
clinical course, and demonstrated relatively severe ambulatory disability based on a median EDSS score 
of 6.0 and frequent assistive device use (65%). On average, the sample demonstrated low 
cardiorespiratory fitness and engaged in low levels of free-living MVPA, consistent with other samples 
of persons with substantial MS disability.[31,32] Regarding physiological criteria for determining 
maximal effort during the incremental exercise test, 66% of participants demonstrated RER values of 
1.10 or greater, and 98% of participants had a HRpeak within 10 beats/min of age-predicted maximum; 
such proportions are consistent with those from other cardiopulmonary exercise test protocols in 
MS.[31] The sample demonstrated substantial CPS impairment, as well as impaired verbal learning and 
memory based on mean age-, sex-, and education-adjusted z-scores of −2.2 and −1.1 SD-units, 
respectively, on the SDMT and CVLT-II. By comparison, the sample demonstrated a lesser degree of 
visuospatial learning and memory impairment based on a mean BVMT-R z-score of −0.8 SD-units. The 
pattern of cognitive performance further was comparable with other progressive MS samples.[4] 
 
Correlations 
 Correlations among cardiorespiratory fitness, free-living MVPA, and BICAMS outcomes are 
presented in Table 2 and depicted in Figures 1-3. When correcting for multiple comparisons, there were 
no statistically significant correlations between VO2peak or WRpeak and SDMT (r=−.01,p=.83;  
r=−.04,p=.49), CVLT-II (r=.05,p=.41; r=.05,p=.44), or BVMT-R (r=−.14,p=.03; r=−.13,p=.03) z-scores, 
respectively. There further were no statistically significant correlations between minutes/day of MVPA 
or percent MVPA and SDMT (r=.06,p=.40; r=.05,p=.49), CVLT-II (r=−.05,p=.44; r=−.07,p=.31), and BVMT-
R (r=.01,p=.88; r=.01,p=.87) z-scores, respectively. The correlations further were not statistically 
significant when adjusting for country. Of note, VO2peak (r=.51), WRpeak (r=.66), minutes/day of MVPA 
(r=.59), and percent MVPA (r=.60) were significantly and strongly correlated with 6MW performance, 




 The current analysis of baseline data from the CogEx trial examined cardiorespiratory fitness 
and free-living MVPA as correlates of cognitive performance in a large, international sample of 
cognitively-impaired persons with progressive MS. The primary novel results indicated that baseline 
measures of cardiorespiratory fitness and free-living MVPA, as cross-sectional components of aerobic 
exercise training, were not associated with cognitive performance in persons with progressive MS, 
given the minimal magnitude of correlation coefficients. The overall lack of observed associations 
suggests that cardiorespiratory fitness and free-living MVPA might not represent primary mechanisms-
of-action for aerobic exercise training effects on cognition in this population. As the null results derive 
from cross-sectional analyses of baseline data, the forthcoming RCT results will better permit inferences 
of causation for aerobic exercise training-related changes in cardiorespiratory fitness and free-living 
MVPA as possible mechanisms for cognitive improvements. This is critical as there is a truncated range 
of scores in the baseline cognitive assessment based on screening criteria (i.e., SDMT scores ≤10th 
percentile), which would reduce the observed correlations.  
 The observed lack of associations among cardiorespiratory fitness, free-living MVPA, and 
cognitive performance did not support our primary hypothesis. That hypothesis was based on previous 
evidence reporting stronger associations among cardiorespiratory fitness, physical activity, and 
cognition in cognitively-impaired compared with non-cognitively impaired persons with predominantly 
relapsing-remitting MS and mild-to-moderate disability.[11,13] The current pattern of results was 
consistent with other research describing disability status as a moderator of the cardiorespiratory 
fitness/cognition relationship in MS, whereby the relationship was not statistically significant in persons 
with moderate-to-severe MS disability (EDSS ≥4.0).[10] This suggests that perhaps ambulatory disability 
status has a stronger influence on the fitness/cognition relationship than cognitive status in this 
population. Indeed, the current sample involved persons with definitive progressive MS and relatively 
severe ambulatory disability (i.e., 55% with EDSS ≥6.0), and it is possible that the progression of the MS 
disease process has overwhelmed the capacity for cardiorespiratory fitness and free-living MVPA to 
influence cognitive performance.[10] 
 Another possible explanation for the overall pattern of correlations that were not statistically 
significant involves a restricted range of cardiorespiratory fitness, free-living MVPA, and cognitive 
performance scores. Indeed, there is evidence that persons with progressive MS and severe ambulatory 
disability have particularly poor cardiorespiratory fitness, engage in less free-living MVPA, and 
demonstrate impaired cognition relative to persons with relapsing-remitting MS and mild-to-moderate 
ambulatory disability.[4,24,32] As expected, the current sample presented with such characteristics, as 
the CogEx trial aims to evaluate the comparative and combined effects of cognitive rehabilitation and 
aerobic exercise training on cognition in CPS-impaired persons with progressive MS. Although screening 
for progressive MS, physical inactivity, and low SDMT scores is advantageous for the design of the CogEx 
RCT[7,14] (i.e., pre-screening participants for the problem being studied), this effectively restricted the 
range of scores on the baseline outcomes, increasing the likelihood of smaller, cross-sectional 
correlations.[33] By extension, given previous reports of statistically significant correlations among 
cardiorespiratory fitness, physical activity, and cognition in primarily relapsing-remitting MS 
samples,[10-13] perhaps larger baseline correlations may have been observed if physical inactivity and 
CPS impairment were not inclusion criteria. 
The inclusion of cardiorespiratory fitness and MVPA outcomes as manipulation checks in the 
forthcoming RCT analyses is critical for documenting the success of the CogEx trial (and for aerobic 
exercise training interventions in general). As the definition of aerobic exercise training involves 
health-enhancing physical activity for improving or maintaining aerobic fitness,[5] documenting 
changes in physical activity and aerobic fitness over time in a RCT is appropriate for interpreting the 
extent to which an intervention condition (i.e., independent variable) was manipulated relative to a 
control condition. That is, the observation of between-group differences in changes in 
cardiorespiratory fitness and MVPA should confirm the separation between the intervention and 
control conditions in a RCT of aerobic exercise training. By extension, within the context of the 
forthcoming RCT results from the CogEx trial, we expect that the conditions involving aerobic exercise 
training will be associated with improved or maintained cardiorespiratory fitness and MVPA relative 
to the conditions involving sham (non-aerobic) exercise, regardless of whether or not changes in those 
outcomes are associated with cognitive improvements (i.e., primary mechanisms-of-action). We 
further note that the inclusion of those outcomes will represent an important addition to the 
evidence base on aerobic exercise effects on cardiorespiratory fitness and free-living MVPA in persons 
with progressive MS.  
Although baseline cardiorespiratory fitness and free-living MVPA were not associated with 
cognitive performance, the current cross-sectional results have important implications for the 
consideration of aerobic exercise training as an approach for managing progressive MS-related 
cognitive impairment. The overall pattern of null correlations suggests that perhaps cardiorespiratory 
fitness and free-living MVPA might not represent primary mechanisms-of-action for aerobic exercise 
training effects on cognition in persons with progressive MS, and other mechanisms might explain 
potential aerobic exercise training-related changes in cognitive performance in this population. For 
example, one conceptual framework and model posits that the processing and integration of 
multisensory input for the physiological regulation of exercise represents the driving force behind 
exercise-related adaptations in brain-systems and function (i.e., cognition) in persons with MS.[34] As 
the CogEx trial involves neuroimaging outcomes,[14] the RCT analyses will allow for testing such a 
hypothesis, in addition to better clarifying the role of aerobic exercise training-related changes in 
cardiorespiratory fitness and free-living MVPA for explaining possible cognitive improvements in persons 
with progressive MS. 
 Interestingly, there were statistically significant and strong associations among 
cardiorespiratory fitness, free-living MVPA, and walking endurance. This is consistent with previously 
reported correlations among those outcomes across the MS disability spectrum.[29] Such a pattern of 
results seemingly suggests against a generalized effect whereby cardiorespiratory fitness and free-living 
MVPA would correlate with multiple domains of functioning (i.e., cognitive-motor coupling)[35] in 
progressive MS. By comparison, perhaps the concept of cognitive-motor coupling and associated 
prediction by cardiorespiratory fitness and free-living MVPA better applies in relapsing-remitting MS.  
 Study strengths include the large, international progressive MS sample and the rigorous 
standardization of outcome assessment methodologies across sites. There are several limitations. Of 
note, this study represents an analysis of baseline data from a parent RCT (i.e., the CogEx trial),[14] and 
was not designed to specifically address cross-sectional correlations among cardiorespiratory fitness, 
free-living MVPA, and cognitive performance. As described above, although a strength of the parent RCT 
involved the pre-screening of physically inactive and CPS-impaired persons with progressive MS, this 
may have restricted the ranges of the outcome measure scores, thereby downwardly biasing the 
correlations in this analysis. Furthermore, the current analyses were cross-sectional and do not allow for 
inferences of causation; however, the RCT analyses should provide such an opportunity. Finally, MRI 
data were not available for the present analysis as an additional outcome measure. This would have 
afforded the opportunity to evaluate neural substrates underlying cardiorespiratory fitness, free-living 
MVPA, walking endurance, and cognition in the present sample. We note that such outcomes will be 
available for the primary RCT analyses in a subsample of patients. 
 
Conclusions 
 Cardiorespiratory fitness and free-living MVPA were not associated with cognitive performance 
in this large, international sample of CPS-impaired persons with progressive MS. Nevertheless, 
cardiorespiratory fitness and free-living MVPA still represent critical manipulation checks for 
documenting the success of RCTs evaluating the effects of aerobic exercise training on cognition in 
progressive MS (i.e., the CogEx trial). This highlights the importance of examining other exercise-related 
mechanisms-of-action for improving cognition and brain health in RCTs in this population. 
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